C07K

Follow

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Subclasses

Not Available
Subclass Title
1/00 General processes for the preparation of peptides
1/02 General processes for the preparation of peptides in solution
1/04 General processes for the preparation of peptides on carriers
1/06 General processes for the preparation of peptides using protecting groups or activating agents
1/08 General processes for the preparation of peptides using protecting groups or activating agents using activating agents

more results

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
9649354 Polypeptide inhibitors of HSP27 kinase and uses therfor Sep 29, 16 May 16, 17 PURDUE RESEARCH FOUNDATION, Purdue Research Foundation
9649355 Compounds and methods for the treatment of vascular disease Jul 31, 14 May 16, 17 ANNEXIN PHARMACEUTICALS AB, Annexin Pharmaceuticals AB
9649356 Method of improving transplant function using soluble complement receptor type I (sCR1) Oct 27, 11 May 16, 17 CELLDEX THERAPEUTICS, INC., CELLDEX THERAPEUTICS INC.
9649359 Peptides and compositions for treatment of joint damage Mar 07, 14 May 16, 17 NOVARTIS AG, Novartis AG
9649361 Compositions and methods for the systemic treatment of arthritis Nov 16, 15 May 16, 17 BAYLOR RESEARCH INSTITUTE, Baylor Research Institute
9649362 Peptide conjugates of GLP-1 receptor agonists and gastrin and their use Jun 10, 15 May 16, 17 ZEALAND PHARMA A/S, Zealand Pharma A/S
9649364 Methods for producing stable therapeutic formulations in aprotic polar solvents Apr 22, 16 May 16, 17 XERIS PHARMACEUTICALS, INC., Xeris Pharmaceuticals Inc.
9649368 Genetically engineered microbial strains including prototheca lipid pathway genes Apr 05, 16 May 16, 17 TERRAVIA HOLDINGS, INC., TerraVia Holdings, Inc.
9649371 Recombinant mumps virus vaccine Feb 24, 12 May 16, 17 UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC., The University of Georgia Research Foundation Inc.
9649374 Neutralizing prolactin receptor antibodies and their therapeutic use Nov 18, 10 May 16, 17 BAYER INTELLECTUAL PROPERTY GMBH, Bayer Intellectual Property GmbH
9649375 Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith Mar 14, 13 May 16, 17 The Administrators of the Tulane Educational Fund, The Administrators of the Tulane Educational Fund; The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC;
9649376 Selective removal of age-modified cells for treatment of atherosclerosis Sep 27, 11 May 16, 17 SIWA CORPORATION, Siwa Corporation
9649377 Methods of using IL-1β compounds to treat familial mediterranean fever (FMF) Jul 28, 15 May 16, 17 NOVARTIS AG, Novartis AG
9649378 Cancer methods Apr 15, 11 May 16, 17 NOVARTIS AG, Not available
9649390 Pyrrolobenzodiazepines and conjugates thereof Mar 13, 14 May 16, 17 MEDIMMUNE LIMITED, MedImmune Limited
9650411 Method of purifying protein Mar 14, 13 May 16, 17 KYOWA HAKKO KIRIN CO., LTD., Kyowa Hakko Kirin Co., Ltd.
9650412 Integrated continuous manufacturing of therapeutic protein drug substances Mar 03, 14 May 16, 17 GENZYME CORPORATION, Genzyme Corporation
9650413 Integrated continuous manufacturing of therapeutic protein drug substances Feb 20, 15 May 16, 17 GENZYME CORPORATION, Genzyme Corporation
9650414 Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof May 29, 15 May 16, 17 SIMON FRASER UNIVERSITY, Simon Fraser University
9650415 Uric acid-lowering agent Jun 20, 14 May 16, 17 SUNTORY HOLDINGS LIMITED, Suntory Holdings Limited

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2017/0135,327 ANIMAL MODELS AND THERAPEUTIC MOLECULES Apr 01, 16 May 18, 17 , Not available
2017/0135,329 GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE Jan 24, 17 May 18, 17 , Not available
2017/0135,326 NON-HUMAN ANIMALS WITH MODIFIED IMMUNOGLOBULIN HEAVY CHAIN SEQUENCES Dec 07, 15 May 18, 17 , Not available
2017/0137,389 LINKER MOLECULE FOR MULTIPLEX RECOGNITION BY ATOMIC FORCE MICROSCOPY (AFM) May 07, 15 May 18, 17 , Not available
2017/0137,460 Short Chain PEGylation of Amino Acid Monomers Glutamine, Lysine and Peptides Formed Thereby Jun 08, 15 May 18, 17 , Not available
2017/0137,461 Affinity Chromatography Devices Jan 19, 17 May 18, 17 , Not available
2017/0137,462 CATIONIC LIPID CORDIARIMIDE HYBRID COMPOUNDS AND A PROCESS FOR PREPARATION THEREOF Jun 10, 15 May 18, 17 , Not available
2017/0137,463 HCV PROTEASE INHIBITORS AND USES THEREOF Jul 05, 16 May 18, 17 , Not available
2017/0137,464 ANTIBODY, EPITOPE TAG AND METHOD FOR DETECTION, CAPTURE AND/OR PURIFICATION OF TAGGED POLYPEPTIDES Jan 15, 16 May 18, 17 , Not available
2017/0137,465 C6S SPECIFIC TRANSPORTER MOLECULES Apr 27, 15 May 18, 17 , Not available
2017/0137,466 PEPTIDE-INDUCED NK CELL ACTIVATION May 08, 15 May 18, 17 , Not available
2017/0137,467 EPITOPE TAG AND METHOD FOR DETECTION AND/OR PURIFICATION OF TAGGED POLYPEPTIDES Nov 16, 16 May 18, 17 , Not available
2017/0137,468 MODULATION OF COMPLEMENT ACTIVITY Jun 12, 15 May 18, 17 , Not available
2017/0137,469 POLYMYXIN DERIVATIVES AS ANTIMICROBIAL COMPOUNDS Apr 01, 15 May 18, 17 , Not available
2017/0137,470 Kv1.3 Potassium Channel Antagonists May 07, 15 May 18, 17 , Not available
2017/0137,471 ANTIMICROBIAL PEPTIDE DENDRIMERS Mar 27, 15 May 18, 17 UNIVERSITAT BERN,
2017/0137,472 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES Jun 08, 15 May 18, 17 ,
2017/0137,473 FLUOROGEN ACTIVATING AND SHIFTING TAG (FAST) Jul 03, 15 May 18, 17 ,
2017/0137,474 PROTEIN ISOLATION Jan 17, 17 May 18, 17 ,
2017/0137,475 EXPRESSION SYSTEM Jul 14, 16 May 18, 17 SMITHKLINE BEECHAM BIOLOGICALS S.A.,

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to follow the Technologies/Sub-Technologies.